De-Mont Research Laboratories (Pvt.) Ltd.
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Sheikhupura · Pakistan
Punjab-based pharmaceutical and healthcare manufacturer within the McOlson Group, focused on medicines and related healthcare products.
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- DeMont Research Laboratories (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- 20-KM Lahore-Sharaqpur Road, Sheikhupura, Pakistan
- Website
- demont.pk ↗
- Phone
- +92 42 35171711; +92 42 35160633
- info@demont.pk
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where De-Mont Research Laboratories (Pvt.) Ltd. is priced against the market
75 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Hepnil | Entecavir | 0.5 mg | Tablet | 30's | 119331 | PKR 6,253.22 | PKR 208.44/tablet | 🔒 Pharma Pro |
| Irbival-H 150 | Irbesartan + Hydrochlorothiazide | 150 mg + 12.5 mg | Tablet | 14's | 094679 | PKR 373.14 | PKR 26.65/tablet | 🔒 Pharma Pro |
| Irbival-H 300 | Irbesartan + Hydrochlorothiazide | 300 mg + 12.5 mg | Tablet | 10's | 103386 | PKR 393.44 | PKR 39.34/tablet | 🔒 Pharma Pro |
| Lemox | Moxifloxacin | 400 mg | Tablet | 5's | 084042 | PKR 849.94 | PKR 169.99/tablet | 🔒 Pharma Pro |
| LeZ-T | Letrozole | 2.5 mg | Tablet | 30's | 094691 | PKR 7,615.05 | PKR 253.84/tablet | 🔒 Pharma Pro |
| Linux Dry Susp | Linezolid | 100 mg/5 mL | Dry suspension | 60ml | 084092 | PKR 444.21 | PKR 7.40/mL | 🔒 Pharma Pro |
| Mastador 75 | Diclofenac sodium + Misoprostol | 75 mg + 200 mcg | Tablet | 20's | 109304 | PKR 470.38 | PKR 23.52/tablet | No comparator |
| Mino Power | Rice powder + Sodium chloride + Potassium chloride + Sodium citrate | 6 g + 0.35 g + 0.3 g + 0.58 g | Sachet | 10's | 084053 | PKR 250.51 | PKR 25.05/sachet | No comparator |
| Mromont | Meropenem | 500 mg | Injection | 1's | 124393 | PKR 1,358.02 | PKR 1,358.02/vial/unit | 🔒 Pharma Pro |
| Mromont | Meropenem | 1000 mg | Injection | 1's | 124394 | PKR 2,538.35 | PKR 2,538.35/vial/unit | 🔒 Pharma Pro |
| Naratine | Loratadine | 10 mg | Tablet | 10's | 121460 | PKR 91.38 | PKR 9.14/tablet | 🔒 Pharma Pro |
| Nexa 40mg InjectionRegistry verified | Esomeprazole as sodium | — | — | — | 104711Official source ↗ | No indexed price | — | — |
| Nif-LA | Nifedipine | 60 mg | Extended-release tablet | 20's | 103302 | PKR 927.65 | PKR 46.38/tablet | No comparator |
| Nif-LA | Nifedipine | 30 mg | Extended-release tablet | 20's | 126609 | PKR 426.44 | PKR 21.32/tablet | No comparator |
| Omnic | Omeprazole | 20 mg | Capsule | 14's | 092567 | PKR 283.40 | PKR 20.24/capsule | 🔒 Pharma Pro |
| Omnic | Omeprazole | 40 mg | Capsule | 14's | 092568 | PKR 492.02 | PKR 35.14/capsule | 🔒 Pharma Pro |
| Omnic | Omeprazole | 40 mg | Capsule | 1's | 104710 | PKR 561.57 | PKR 561.57/capsule | 🔒 Pharma Pro |
| Omnic Plus | Omeprazole + Sodium bicarbonate | 40 mg + 1680 mg | Sachet | 10's | 093147 | PKR 336.72 | PKR 33.67/sachet | 🔒 Pharma Pro |
| Omnic Plus | Omeprazole + Sodium bicarbonate | 20 mg + 1680 mg | Sachet | 10's | 104633 | PKR 180.91 | PKR 18.09/sachet | 🔒 Pharma Pro |
| Piprobct | Piperacillin + tazobactam | 2000 mg + 250 mg | Injection | 1's | 127329 | PKR 431.52 | PKR 431.52/vial/unit | No comparator |
| Piprobct | Piperacillin + tazobactam | 4000 mg + 500 mg | Injection | 1's | 127330 | PKR 981.07 | PKR 981.07/vial/unit | No comparator |
| Propana | Propranolol | 40 mg | Tablet | 100's | 119332 | PKR 222.11 | PKR 2.22/tablet | 🔒 Pharma Pro |
| Propana | Propranolol | 40 mg | Tablet | 50's | 119332 | PKR 111.69 | PKR 2.23/tablet | 🔒 Pharma Pro |
| Regmont | Clomifene citrate | 50 mg | Tablet | 10's | 099905 | PKR 380.10 | PKR 38.01/tablet | 🔒 Pharma Pro |
| Remedol | Tramadol + Paracetamol | 325 mg + 37.5 mg | Tablet | 20's | 084041 | PKR 361.15 | PKR 18.06/tablet | No comparator |
| Smoothie | Sodium chloride + Glucose + Potassium chloride + Trisodium citrate | 13.5 g + 2.9 g + 2.6 g + 1.5 g | Sachet | 20's | 084050 | PKR 357.86 | PKR 17.89/sachet | No comparator |
| Smoothie | Sodium chloride + Glucose + Potassium chloride + Trisodium citrate | 13.5 g + 2.9 g + 2.6 g + 1.5 g | Sachet | 10's | 084050 | PKR 165.65 | PKR 16.57/sachet | No comparator |
| Sumacara | Sumatriptan + Naproxen | 85 mg + 500 mg | Tablet | 10's | 119061 | PKR 1,573.78 | PKR 157.38/tablet | No comparator |
| Tacoma | Terbinafine | 125 mg | Tablet | 10's | 099909 | PKR 518.49 | PKR 51.85/tablet | 🔒 Pharma Pro |
| Tacoma | Terbinafine | 250 mg | Tablet | 10's | 099910 | PKR 828.25 | PKR 82.83/tablet | 🔒 Pharma Pro |
| Tenomont | Tenofovir disoproxil | 300 mg | Tablet | 30's | 121456 | PKR 4,378.65 | PKR 145.96/tablet | 🔒 Pharma Pro |
| Teracitam | Levetiracetam | 500 mg/5 mL | Injection | 5ml x 1's | 092555 | PKR 665.03 | PKR 133.01/mL | 🔒 Pharma Pro |
| Teracitam | Levetiracetam | 250 mg | Tablet | 10's | 103389 | PKR 525.79 | PKR 52.58/tablet | 🔒 Pharma Pro |
| Teracitam | Levetiracetam | 500 mg | Tablet | 10's | 103390 | PKR 873.02 | PKR 87.30/tablet | 🔒 Pharma Pro |
| Trimont | Clotrimazole | 500 mg | Vaginal tablet | 1's | 121461 | PKR 81.23 | PKR 81.23/tablet | 🔒 Pharma Pro |
| Vorimont | Voriconazole | 200 mg | Tablet | 10's | 118989 | PKR 1,396.09 | PKR 139.61/tablet | 🔒 Pharma Pro |
| Vorimont | Voriconazole | 50 mg | Tablet | 10's | 118990 | PKR 507.67 | PKR 50.77/tablet | 🔒 Pharma Pro |
| Vorimont | Voriconazole | 40 mg/mL | Suspension | 75ml | 118991 | PKR 1,986.26 | PKR 26.48/mL | 🔒 Pharma Pro |
| Vorimont | Voriconazole | 40 mg/mL | Suspension | 60ml | 118991 | PKR 1,675.31 | PKR 27.92/mL | 🔒 Pharma Pro |
| Zanoc | Fluconazole | 150 mg | Capsule | 1's | 084049 | PKR 267.77 | PKR 267.77/capsule | 🔒 Pharma Pro |
| Zanoc Dry Susp | Fluconazole | 50 mg/5 mL | Dry suspension | 35ml | 084094 | PKR 375.76 | PKR 10.74/mL | 🔒 Pharma Pro |
| Zilviro | Aciclovir | 200 mg | Tablet | 10's | 121459 | PKR 253.83 | PKR 25.38/tablet | 🔒 Pharma Pro |
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.